Safety and Efficacy of SFPP in Knee Osteoarthritis

Osteoarthritis Knee Pain Clinical Trial

Official title:
Randomized Controlled Study to Evaluate the Safety and Efficacy of SFPP in Knee Osteoarthritis Using Diclofenac Gel as the Comparator

Status Completed

Clinical Trial Summary

The objectives of this study are to demonstrate the non-inferiority of esflurbiprofen plaster (SFPP) 40 mg applied for 2 weeks to diclofenac gel, the comparator, in terms of efficacy in patients with knee osteoarthritis (OA) and to examine the safety of SFPP.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03434197
Study type	Interventional
Source	Taisho Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	February 5, 2018
Completion date	January 11, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01018680` - A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis	Phase 3
Completed	`NCT00790790` - A Study in the Treatment of Osteoarthritis Knee Pain	Phase 2
Completed	`NCT00408421` - Duloxetine Versus Placebo for Osteoarthritis Knee Pain	Phase 3
Completed	`NCT00945945` - A Study of Duloxetine in Patients With Osteoarthritis Knee Pain	Phase 3
Completed	`NCT00433290` - Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain	Phase 3